neuropeptide W-23 (Human) [5715]
neuropeptide W-23 (Human)
| SMILES | CSCCC(NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(C)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(C)NC(=O)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(CCCCN)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(N)Cc1c[nH]c2ccccc12)C(C)C)C(C)O)C(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)O |
| InChIKey | AKMMHLDUORFPQZ-UHFFFAOYSA-N |
| Sequence | WYKHVASPRYHTVGRAAGLLMGL |
| HELM | PEPTIDE1{W.Y.K.H.V.A.S.P.R.Y.H.T.V.G.R.A.A.G.L.L.M.G.L}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | -7.111 |
| Molecular weight (Da) | 2582.4 |
No bioactivity data available.
neuropeptide W-23 (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|